Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction
AAPM&R Members in the News: April 2018
Academy Introduces Reimbursement Resources for Residents
April Coding Q&A
AAPM&R Signs on to AMA Letter Urging CMS to Reduce 2018 Reporting Period
Apply to Participate in the 2018 Center for Medicare & Medicaid Services (CMS) Study on Burdens Associated with Reporting Quality Measures to Receive Improvement Activity Credit for 2018
Coastal Meds to Recall All Products Marketed as Sterile
Sterile Injectable Products by Premier Pharmacy Labs: Recall - Lack of Sterility Assurance
Share Your Feedback About Continuing Board Certification by May 11
Look Up if You Need to Participate in MIPS in 2018
Academy Advocacy Win: Michigan BCBS Blue Care Network Will Continue to Cover Hyaluronic Acid Injections Until Further Notice
43 U.S. Senators Vow to Stop Passage of H.R. 620: The ADA Education and Reform Act of 2017
Look for Your April Issue of The Physiatrist
CMS Updates Rates and Expands Opioid Policies Under Medicare Advantage and Part D
Open Payments Review Open Now Through May 15
Updated List of DMEPOS HCPCS Codes Potentially Subject to Pre-authorization
CMS Extends the MIPS 2017 Data Submission Deadline from March 31 to April 3 at 8 PM EDT
AAPM&R Members in the News: March 2018
AAPM&R Receives ACCME Accreditation with Commendation
AAPM&R Submits Joint Response to HHS on Drug Pricing Proposals